With the promulgation of the new medical reform policies of the state, the domestic pharmaceutical industry has started the new round of sequencing. The brand building of Chinese pharmaceutical industry is being accelerated. Recently, the “Selection of Top Ten Brands of Pharmaceutical Industry of 2008” jointly carried out by Huicong pharmaceutical industry net and China Pharmaceutical Enterprises Management Association was announced, with 60 famous pharmaceutical enterprises getting 6 awards of different categories respectively. Yangtze River Pharmaceutical Group stood out from the 579 candidate enterprises by its outstanding contribution in the industry and good social reputation, being ranked on top of the list. Enterprises that got this special honor include famous domestic and foreign pharmaceutical companies such as Tongrentang, Xi’an Janssen and United Laboratories.
For many years, Yangtze River Pharmaceutical Group has adhered to the concept of “seeking for progress and protecting public health”, insisting on the development way of “innovation and high quality to the benefit of people”, dedicated to the service of health of the human beings. After 38 years of technology accumulation and continuously development, Yangtze River now has more than 10 series of products combinations and several state-level innovation R&D platforms, having become a trans-regional large-scale pharmaceutical group corporation of the state integrating science, industry and trading, combining production, studying and researches. The enterprise has been ranked among “the top 500 largest enterprise groups of China”, “the top 500 taxpayers of China”, and “the first batch of innovative enterprises of the state”. Its popularity and influence inside the industry and on the society have been strengthened day by day.
It is said that this activity is titled with “establishing the model of the industry and creating independent brand”, and in accordance with “fair, equal and open” rules, strict assessment has been carried out on the enterprises to be selected so as to tap the enterprises’ brand values, advocate their innovation spirits and praise their responsibilities undertaken to the society and the outstanding contributions made. The selection mainly adopted such two ways as online voting and text message voting. With the duration of more than 5 months, 1.3 million votes online and more than 25,000 votes from text messages and over 6,000 off-line paper votes were sent back, having generated wide influence in upper, medium and lower reaches of the whole pharmaceutical industrial chain.